Navigation Links
Improved cancer treatments the focus of $6 milion research project
Date:9/6/2012

Research into the natural process of cell death, its role in the development of blood cancers and harnessing cell death to improve cancer therapies has seen a Walter and Eliza Hall Institute research team from Melbourne, Australia, awarded a grant of more than $6 million by the US-based Leukemia & Lymphoma Society.

The grant of $1.25 million a year for five years was one of four awarded through the Leukemia & Lymphoma Society's Specialized Center of Research (SCOR) program.

The Walter and Eliza Hall Institute team was the only team outside the United States awarded a SCOR program grant.

Professor Jerry Adams, director of the SCOR program and joint head of the Institute's Molecular Genetics of Cancer division, said the research team had been investigating apoptosis, the natural process of cell death, for more than two decades.

"Our bodies make billions of blood cells every day, and, to make room, billions of other blood cells must undergo apoptosis," Professor Adams said. "If some cells fail to die when they should, they can develop into leukaemia, lymphoma or multiple myeloma. We are studying how impaired apoptosis contributes to the development of blood cell cancers and renders the malignant cells more resistant to current therapies."

In the late 1980s and early 1990s, institute researchers discovered that the Bcl-2 protein family promoted the development of blood cancers by preventing the death of cancerous cells and also helped cancer cells resist anti-cancer therapies. This put apoptosis centre stage in cancer research.

"Nearly all anti-cancer therapies act through the Bcl-2 apoptotic switch," Professor Adams said, "but they affect it indirectly. To improve cancer treatments we are investigating the effectiveness of new drugs, used either alone or in combination with other therapies, that directly engage the apoptotic machinery and flip the cell death switch. We have already identified some promising drug candidates and this new funding will allow us to further investigate their effectiveness and the usefulness of other new anti-cancer agents."


'/>"/>
Contact: Ms. Penny Fannin
fannin@wehi.edu.au
Walter and Eliza Hall Institute
Source:Eurekalert  

Related medicine news :

1. 30-day mortality after AMI drops with improved treatment
2. PSA Testing Linked to Improved Prostate Cancer Survival
3. Prostate cancer survival rates improved since introduction of PSA testing
4. East meets West to bring improved sanitation and hygiene practices to Vietnam, Cambodia
5. By studying animal health, researchers find improved ways for developing, testing cancer therapies
6. Health care organizations quest for reduced costs and improved quality
7. HCOs find risks & opportunities in quest for reduced costs & improved quality
8. Is Improved Vaccine Causing Whooping Cough Outbreaks?
9. Expanding Medicaid to low-income adults leads to improved health, fewer deaths
10. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
11. PaleoMeal Organic Whey Protein Formula Improved According to Rockwell Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Improved cancer treatments the focus of $6 milion research project
(Date:5/31/2016)... Florida (PRWEB) , ... May 31, 2016 , ... ... Jay Butch of CertainTeed Corporation, he knew it was something that contractors should ... state-of-the-art and cutting-edge as it gets,” says Butch, CertainTeed’s Director of Contractor Programs. ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only ... the industry as a whole. On June 2, Northbound CEO Mike Neatherton and COO ... (WCSAD) and presenting the opening plenary on “Leadership: The Journey to Authenticity” with Onsite ...
(Date:5/31/2016)... ... May 31, 2016 , ... WaterField Designs, an innovative ... announces the waxed-canvas and leather Duo Dopp Kit , the ideal gift upgrade ... ballistic nylon, the Duo is smartly designed for Dad’s grooming routine. Two ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Interest is on ... screening tool and as an orthogonal tool for RNAi hit validation. A key reason ... specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. ...
(Date:5/31/2016)... Tel Aviv (PRWEB) , ... May 31, 2016 ... ... in the May 4, 2016 Cool Vendors in Security Infrastructure Protection report by ... areas and publishes a series of research reports evaluating these innovative vendors and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Hutchison China MediTech (Chi-Med) ... the highly lucrative global oncology and immunology markets. ... first-in-class or best-in-class tyrosine kinase inhibitor (TKI) drugs, ... partners. HCM,s profitable Chinese healthcare business continues to ... progress of the mid-to-late-stage pipeline during 2016-17 (including ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... , May 26, 2016 ... has matured into an essential life science tool for ... development applications. BCC Research reveals in its new report ... second growth phase, one powered by a range of ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
Breaking Medicine Technology: